Cargando…

Type 2 diabetes mellitus compromises the survival of diffuse large B-cell lymphoma patients treated with (R)-CHOP – the PLRG report

Comorbidities impair the prognosis of diffuse large B-cell lymphoma (DLBCL). Type 2 diabetes mellitus (DMT2) increases the risk of other comorbidities, e.g., heart failure (HF). Thus, we hypothesized that pre-existing DMT2 may negatively affect the outcome of DLBCL. To verify this, DLBCL patients tr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Drozd-Sokolowska, Joanna, Zaucha, Jan Maciej, Biecek, Przemyslaw, Giza, Agnieszka, Kobylinska, Katarzyna, Joks, Monika, Wrobel, Tomasz, Kumiega, Beata, Knopinska-Posluszny, Wanda, Spychalowicz, Wojciech, Romejko-Jarosinska, Joanna, Fischer, Joanna, Wiktor-Jedrzejczak, Wieslaw, Dlugosz-Danecka, Monika, Giebel, Sebastian, Jurczak, Wojciech
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7044262/ https://www.ncbi.nlm.nih.gov/pubmed/32103128 http://dx.doi.org/10.1038/s41598-020-60565-7

Ejemplares similares

A survey across orbital lymphoma in Poland: Multicenter retrospective study of polish lymphoma research group (PLRG)
por: Kalicińska, Elżbieta, et al.
Publicado: (2022)

First‐line R‐CVP versus R‐CHOP induction immunochemotherapy for indolent lymphoma with rituximab maintenance. A multicentre, phase III randomized study by the Polish Lymphoma Research Group PLRG4
por: Walewski, Jan, et al.
Publicado: (2019)

Bing-Neel Syndrome, a Rare Presentation of Waldenström Macroglobulinemia—A Multicenter Report by the Polish Lymphoma Research Group
por: Drozd-Sokołowska, Joanna, et al.
Publicado: (2022)

The average relative dose intensity of R‐CHOP is an independent factor determining favorable overall survival in diffuse large B‐cell lymphoma patients
por: Długosz‐Danecka, Monika, et al.
Publicado: (2019)

High efficacy of BGD (bendamustine, gemcitabine, and dexamethasone) in relapsed/refractory Hodgkin Lymphoma
por: Swoboda, Ryszard, et al.
Publicado: (2021)

Correction to: High efficacy of BGD (bendamustine, gemcitabine, and dexamethasone) in relapsed/refractory Hodgkin lymphoma
por: Swoboda, Ryszard, et al.
Publicado: (2021)

Tafasitamab for the treatment of relapsed or refractory diffuse large B-cell lymphoma
por: Salles, Gilles, et al.
Publicado: (2021)

The use of Yttrium-90 Ibritumomab Tiuxetan ((90)Y-IT) as a consolidation therapy in high-risk patients with diffuse large B-cell lymphoma ineligible for autologous stem-cell transplantation
por: Jurczak, Wojciech, et al.
Publicado: (2015)

Ofatumumab with iphosphamide, etoposide and cytarabine for patients with transplantation‐ineligible relapsed and refractory diffuse large B‐cell lymphoma
por: Paszkiewicz‐Kozik, Ewa, et al.
Publicado: (2022)

Liposomal cytarabine in the prophylaxis and treatment of CNS lymphoma: toxicity analysis in a retrospective case series study conducted at Polish Lymphoma Research Group Centers
por: Jurczak, Wojciech, et al.
Publicado: (2015)

Sinusitis in patients undergoing allogeneic bone marrow transplantation – a review()
por: Drozd-Sokolowska, Joanna Ewa, et al.
Publicado: (2016)

Autologous stem cell transplantation as consolidation therapy for patients with peripheral T cell lymphoma in first remission: long-term outcome and risk factors analysis
por: Czyz, Anna, et al.
Publicado: (2013)

Ibrutinib does not have clinically relevant interactions with oral contraceptives or substrates of CYP3A and CYP2B6
por: de Jong, Jan, et al.
Publicado: (2020)

P017: The role of baseline bulk and dissemination measures as predictors of progression in advanced Hodgkin lymphoma
por: Taszner, Michal, et al.
Publicado: (2022)

Elevated level of PLRG1 is critical for the proliferation and maintenance of genome stability of tumor cells
por: Choi, Hyunji, et al.
Publicado: (2023)

Prognostic Value of the Immunological Subtypes of Adolescent and Adult T-Cell Lymphoblastic Lymphoma; an Ultra-High-Risk Pro-T/CD2(−) Subtype
por: Ostrowska, Beata, et al.
Publicado: (2021)

The first case of human autochtonous subconjunctival dirofilariosis in Poland and MALT lymphoma as possible consequence of this parasitosis
por: Borkowski, Piotr K, et al.
Publicado: (2015)

COVID-19 in Adult Patients with Hematological Malignancies—Lessons Learned after Three Years of Pandemic
por: Hus, Iwona, et al.
Publicado: (2023)

Primary mediastinal B-cell lymphoma – metabolic and anatomical features in 18FDG-PET/CT and response to therapy
por: Kocurek, Anna, et al.
Publicado: (2016)

Clinicopathologic retrospective analysis of blastic plasmacytoid dendritic cell neoplasms
por: Owczarczyk-Saczonek, Agnieszka, et al.
Publicado: (2018)

Diagnostic difficulties of AH1N1 influenza infection in children with acute lymphoblastic leukemia: Two case reports
por: Zawitkowska, Joanna, et al.
Publicado: (2020)

Hematopoietic stem cell mobilization with the reversible CXCR4 receptor inhibitor plerixafor (AMD3100)—Polish compassionate use experience
por: Basak, Grzegorz Wladyslaw, et al.
Publicado: (2010)

Genetic heterogeneity in primary and relapsed mantle cell lymphomas: Impact of recurrent CARD11 mutations
por: Wu, Chenglin, et al.
Publicado: (2016)

High efficacy and safety of VTD as an induction protocol in patients with newly diagnosed multiple myeloma eligible for high dose therapy and autologous stem cell transplantation: A report of the Polish Myeloma Study Group
por: Hus, Iwona, et al.
Publicado: (2019)

The Real-World Evidence on the Fragility and Its Impact on the Choice of Treatment Regimen in Newly Diagnosed Patients with Multiple Myeloma over 75 Years of Age
por: Tyczyńska, Agata, et al.
Publicado: (2023)

Chemotherapy-Related Toxicity, Nutritional Status and Quality of Life in Precachectic Oncologic Patients with, or without, High Protein Nutritional Support. A Prospective, Randomized Study
por: Ziętarska, Monika, et al.
Publicado: (2017)

Nutritional status assessment in colorectal cancer patients qualified to systemic treatment
por: Ziętarska, Monika, et al.
Publicado: (2017)

Pattern electroretinogram (PERG) in the early diagnosis of normal-tension preperimetric glaucoma: a case report
por: Karaśkiewicz, Joanna, et al.
Publicado: (2013)

RNA Helicase DHX37 Facilitates Liver Cancer Progression by Cooperating with PLRG1 to Drive Superenhancer-Mediated Transcription of Cyclin D1
por: Liu, Zhen, et al.
Publicado: (2022)

Comparison of Computed Tomography Scoring Systems in Patients with COVID-19 and Hematological Malignancies
por: Hałaburda-Rola, Marta, et al.
Publicado: (2023)

Correlation between Choroidal Neovascularization Shown by OCT Angiography and Choroidal Thickness in Patients with Chronic Central Serous Chorioretinopathy
por: Gołębiewska, Joanna, et al.
Publicado: (2017)

Comparison of Adrenal Tumor Size in Ultrasound Examinations with and without the Use of a Contrast Agent
por: Winder, Mateusz, et al.
Publicado: (2019)

Comparative transcriptome analysis of a lowly virulent strain of Erwinia amylovora in shoots of two apple cultivars – susceptible and resistant to fire blight
por: Puławska, Joanna, et al.
Publicado: (2017)

Editor's Note to ‘Identification of peptide inhibitors of pre-mRNA splicing derived from the essential interaction domains of CDC5L and PLRG1’
Publicado: (2022)

Interleukin-31 is overexpressed in skin and serum in cutaneous T-cell lymphomas but does not correlate to pruritus
por: Olszewska, Berenika, et al.
Publicado: (2020)

Atypical chronic myeloid leukaemia – a rare subtype of myelodysplastic/myeloproliferative neoplasm
por: Drozd-Sokołowska, Joanna E., et al.
Publicado: (2018)

Hepatitis B virus screening in patients with non-Hodgkin lymphoma in clinical practice in Poland – a report of the Polish Lymphoma Research Group
por: Kalinka, Ewa, et al.
Publicado: (2019)

The Phase 3 Study ECHELON-1 Evaluating Brentuximab Vedotin in Patients With Newly Diagnosed Hodgkin Lymphoma Leaves Important Questions Unanswered
por: Borchmann, Peter, et al.
Publicado: (2018)

Therapeutic Potential of Olfactory Ensheathing Cells and Mesenchymal Stem Cells in Spinal Cord Injuries
por: Anna, Zadroga, et al.
Publicado: (2017)

Corrigendum to “Therapeutic Potential of Olfactory Ensheathing Cells and Mesenchymal Stem Cells in Spinal Cord Injuries”
por: Zadroga, Anna, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_rl7fmp4ipmp76vv5pib8g55q3m